Skip to content
All news
Analysis

Ares Capital Fair Value Cut as Analysts Turn Cautious

Ares Capital (ARCC) fair value estimate was cut from about $22.64 to $20.77 in one model, reflecting growing analyst caution. Several firms trimmed price targets and reset ratings, citing risks around earnings, dividend coverage, and credit quality.

June 28, 2026
2 min read
Source: Simply Wall St.
Share:

Key Numbers

previous fair value
22.64
new fair value
20.77

Ares Capital (ARCC) is back in focus after its fair value estimate in one model moved from about $22.64 to roughly $20.77, putting a tighter ceiling on where some analysts see the stock. Street commentary has tilted more cautious, with several firms trimming price targets and resetting ratings as they weigh risks around earnings, dividend coverage, and credit quality.

Recommendation Change

  • Previous Target: $22.64 (fair value estimate)
  • New Target: $20.77 (updated fair value)
  • Rating: Shifted to cautious with multiple downgrades

Analyst Rationale

Analysts cite risks to earnings, dividend coverage, and credit quality as reasons for the lower valuation. The updated model suggests the stock may be approaching its true fair value given these headwinds.

Context

Specific analysts or further downgrade details were not disclosed. The development comes amid broader pressure on BDCs from interest rate volatility and credit quality concerns.

Conclusion

Investors should monitor earnings, dividend coverage, and credit quality developments. The fair value cut reflects increased caution but does not constitute a buy or sell recommendation.

Frequently Asked Questions

Ares Capital (ARCC) is a business development company (BDC) that focuses on financing middle-market companies.

Found this useful? Share it

Share:
This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.